...
首页> 外文期刊>Pharmacology and Therapeutics: The Journal of the International Encyclopedia of Pharmacology and Therapeutics >Pluripotent stem cell differentiation into vascular cells: a novel technology with promises for vascular re(generation).
【24h】

Pluripotent stem cell differentiation into vascular cells: a novel technology with promises for vascular re(generation).

机译:多能干细胞分化为血管细胞:一种有望使血管再生的新技术。

获取原文
获取原文并翻译 | 示例
           

摘要

Several types of stem and progenitor cells are currently under investigation for their potential to accomplish vascular regeneration. This review focuses on embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs). We will discuss the technologies allowing for their derivation, culture expansion and maintenance in a pluripotent status. Moreover, both ESCs and iPSCs can be differentiated in endothelial cells (ECs) and mural cell, including vascular smooth muscle cells (VSMCs). Here, we will describe the involvements of growth factors (vascular endothelial growth factors-VEGFs-, platet-derived growth factors-PDGFs-), Wnt and Notch signal pathways, reactive oxygen species (ROS), histone deacetylases (HDACs), and microRNAs (miRNAs) in vascular cell differentiation from pluripotent stem cells. We will additionally describe the therapeutic potential of stem cells for vascular medicine.
机译:目前正在研究几种类型的干细胞和祖细胞实现血管再生的潜力。这篇综述着重于胚胎干细胞(ESCs)和诱导多能干细胞(iPSCs)。我们将讨论允许其衍生,扩展和维持多能状态的技术。此外,ESC和iPSC均可在内皮细胞(EC)和壁画细胞(包括血管平滑肌细胞(VSMC))中分化。在这里,我们将描述生长因子(血管内皮生长因子-VEGFs,血小板衍生的生长因子-PDGFs-),Wnt和Notch信号途径,活性氧(ROS),组蛋白脱乙酰酶(HDAC)和microRNA的参与。 (miRNA)从多能干细胞分化为血管细胞。我们还将另外描述干细胞在血管医学中的治疗潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号